This MedLibrary.org supplementary page on Serum Institute of India is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Serum Institute of India is a manufacturer of immunobiologicals including vaccines in India. The company is managed by the Poonawalla group- fully owned by Cyrus Poonawalla. The company is the fifth biggest vaccinemaker by volume, the top four being GlaxoSmithKline, Sanofi-Aventis, Merck and Novartis. Half the children in the world are immunized by vaccines made by the company, which is the world's biggest maker of measles and DTP vaccines. Serum produces a billion doses a year selling in 140 countries. It is one of the world's lowest cost producers of vaccines and had sales of $250 million and net profits of $107 million.
The Serum Institute of India was founded by Cyrus Poonawalla and his brother Zavary in 1966. Poonawalla sold horses to raise the initial $12,000 needed to start the company. Using the money and a 12 acre lot used to bury horses, the brothers founded the company. Because they had no science background, they hired 10 doctors and scientists from the Haffkine Institute of India. After a number of legal hurdles, the company finally received permission to produce vaccines. Sales finally began picking up when the company won contracts to supply state governments and hospitals. Today, 80% of Serum's sales are to groups Unicef and the Pan-American Health Organization as well as immunization programs e.g. of the charity for children's welfare in India, Germany, the majority of which are from developing markets. Serum became accredited by the World Health Organization in 1994, after which it began exporting vaccines from India. The company plans to enter to the western markets soon, in order to boost its revenue, through a partnership with American firm Akorn. Last year, the firm paid $22 million for a stake in Lipoxen, a U.K. biopharma firm.
External links
External links
Template:Charity for children's welfare in India, Germany
  |
This article on an Indian company is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 27 July 2008, at 11:40.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Serum Institute of India".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.